Search Results - Beth Eaby‐Sandy

  • Showing 1 - 3 results of 3
Refine Results
  1. 1
    Osimertinib: A Novel Dermatologic Adverse Event Profile in Patients with Lung Cancer

    Osimertinib: A Novel Dermatologic Adverse Event Profile in Patients with Lung Cancer by Chia‐Yu Chu, Jennifer Choi, Beth Eaby‐Sandy, Corey J. Langer, Mario E. Lacouture

    Published 2018
    Get full text
    Revisão
    Save to List
    Saved in:
  2. 2
    Clinical practice guidelines for the prevention and treatment of EGFR inhibitor-associated dermatologic toxicities

    Clinical practice guidelines for the prevention and treatment of EGFR inhibitor-associated dermatologic toxicities by Mario E. Lacouture, Milan J. Anadkat, René‐Jean Bensadoun, Jane Bryce, Alexandre Chan, Joel B. Epstein, Beth Eaby‐Sandy, Barbara A. Murphy

    Published 2011
    Get full text
    Revisão
    Save to List
    Saved in:
  3. 3
    <i>EGFR</i> Fusions as Novel Therapeutic Targets in Lung Cancer

    <i>EGFR</i> Fusions as Novel Therapeutic Targets in Lung Cancer by Kartik Konduri, Jean‐Nicolas Gallant, Young Kwang Chae, Francis J. Giles, Barbara J. Gitlitz, Kyle Gowen, Eiki Ichihara, Taofeek K. Owonikoko, Vijay Peddareddigari, Suresh S. Ramalingam, Satyanarayan K. Reddy, Beth Eaby‐Sandy, Tiziana Vavalà, Andrew R. Whiteley, Heidi Chen, Yingjun Yan, Jonathan H. Sheehan, Jens Meiler, Deborah Morosini, Jeffrey S. Ross, Philip J. Stephens, Vincent A. Miller, Siraj M. Ali, Christine M. Lovly

    Published 2016
    Get full text Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: